Механизмы гибели клеток при действии оливомицина и его производных
Диссертация
Антибиотики-производные ауреоловой кислоты — оливомицин, хромомицин A3 и митрамицин — открыты как высоко активные соединения, вызывающие гибель бактерий. Правомерно предположить, что соединения этого химического класса окажутся активными для клеток эукариот, в частности, для опухолевых клеток человека. Это свойство данной группы антибиотиков может найти применение в терапии злокачественных… Читать ещё >
Список литературы
- Брикенштейн В.Х., Патина JI.P., Баренбойм Г. М. Стереохимия и кинетика взаимодействие с ДНК противоопухолевого антибоотика оливомицина. // Молекулярная биология. 1984. — Том. 186 — С. 1606−1616.
- Гаузе Г. Ф. Противоопухолевые антибиотики. // Медицина. — 1971. С. 4070.
- Гаузе Г. Ф., Дудник Ю. В. Противоопухолевые антибиотики. // Медицина. -1987.-С. 13−14.
- Кучкарев Р. Н Опыт клинического изучения новых противоопухолевых антибиотиков хризомалина и оливомицина. Автореферат дисс. канд. М. 1966.
- Харкевич Д.А. Фармакология // ГЭОТАР-Мед. 2006. — С. 643−665.
- Akao Y., Yamada Н., Nakagawa Y. Arsenic-induced apoptosis in malignant cells in vitro. // Leuk Lymphoma. 2000. — Vol. 37. — P. 53−63.
- Arima Y., Nitta M., Kuninaka S. Transcriptional blockade induces p53-dependent apoptosis associated with translocation of p53 to mitochondria. // J. Biol. Chem. 2005. — Vol. — 280(19). — P. 19 166−19 176.
- Arur S., Uche U.E., Rezaul K. Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. // Dev. Cell. 2003. — Vol. 4. — P. 587−598.
- Ashkenazi A., Dixit V.M. Death receptors: signaling and modulation. // J. Hepatol. 2003. — Vol. 39. -P. 883−885.
- Bakkenist C.J., Kastan M.B., Initiating cellular stress responses. // Cell. -2004.-Vol. 9.-P. 9−17.
- Berlin Y.U., Kiseleva O.A., Kolosov M.N. Aureolic acid group of anti-tumour antibiotics. //Nature.- 1968.- Vol. 13.-P. 193−194.
- Borner С., Olivier R., Martinou I. Dissection of functional domains in Bcl-2 alpha by site-directed mutagenesis. // Biochem. Cell Biol. 1994. -Vol. 72(11−12). — P. 463−469.
- Bortner C.D., Oldenburg N.B., Cidlowski J.A. The role of DNA fragmentation in apoptosis. // Trends Cell Biol. 1995. — Vol. 5. — P. 21−26.
- Bortner CD, Oldenburg NB, Cidlowski JA. The role of DNA fragmentation in apoptosis. // Trends Cell Biol. 1995. — Vol. 5 — P. 21−26.
- Brown J., Attardi L.D. The role of apoplosis in cancer and treatment response. //Nat. Rev. Cancer. 2005. — Vol. 5. — P. 231−237.
- Сапера E.T., Scassa M.E., Ceruti J.M. INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions. // IUBMB Life. 2007. — Jul. 59. — P. 419−426.
- Cliby W.A., Lewis K.A., Lilly K.K. et al. S phase and G2 arrests induced by topoisomerase I poisons are dependent on ATR kinase function. // J. Biol. Chem. 2002. — Vol. 277(2). — P. 1599−1606.
- Crompton M., Viiji S., Doyle V. The mitochondrial permeability transition pore. // Biochem. Soc. Symp. 1999. — Vol. 66. — P. 167−179.
- Denecker G., Vercammen D., Declercq W., Apoptotic and necrotic cell death induced by death domain receptors. // Cell. Mol. Life Sci. 2001. — Vol. 58(3) — P. 356 370.
- Derheimer F.A., Chang C.W., Ljungman M. Transcription inhibition: a potential strategy for cancer therapeutics. // Eur. J. Cancer. — 2005. Vol. 41(16). — P. 2569−2576.
- Desagher S., Martinou J.C. Mitochondria as the central control point of apoptosis. // Trends Cell Biol. 2000. — Vol. 10(9). — P. 369−377.
- Diez-Roux G., Lang R.A. Macrophages induce apoptosis in normal cells in vivo. // Development. 1997. — Vol.124. — P. 3633−3638.
- Eastham J.A. In vivo gene therapy with p53 or p21 adenovirus for prostate cancer.//Cancer Res. 1995.-Vol. 55.-P. 5151−5155.
- Enari M., Sakahira H., Yokoyama H. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. // Nature. 1998. — Vol. 391(6662).-P. 43−50.
- Fadok V.A., Chimini G. The phagocytosis of apoptotic cells. // Semin. Immunol. 2001. — Vol. 13. — P. 365−372.
- Falck J., Mailand N., Syljuasen R.G. et al. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. // Nature. 2001. -Vol. 410(6830). — P. 842−847.
- Ferraro-Peyret C., Quemeneur L., Flacher M. Caspase-independent phosphatidylserine exposure during apoptosis of primary T lymphocytes. // J Immunol. -2002.-Vol. 169(9).- P. 4805−4810.
- Festjens N., van Gurp M., van Loo G. Bcl-2 family members as sentinels of cellular integrity and role of mitochondrial intermembrane space proteins in apoptotic cell death. // Acta Haematol. 2004. — Vol. 111. — P. 7−27.
- Fesus L., Madi A., Balajthy Z. Transglutaminase induction by various cell death and apoptosis pathways. // Experientia. 1996. — Vol. 31. — P. 942−949.
- Flatten K., Dai N.T., Vroman B.T. et al. The role of checkpoint kinase 1 in sensitivity to topoisomerase I poisons. // J. Biol. Chem. 2005. — Vol. 280(14). — P. 14 349−14 355.
- Foo S.Y., Nolan G.P. NF-kappaB to the rescue: RELs, apoptosis and cellular transformation. // Trends Genet. 1999. — Vol. 15(6). — P. 229−235.
- Freebern W.J., Smith J.L., Chaudhry S.S. Novel cell-specific and dominant negative anti-apoptotic roles of p73 in transformed leukemia cells. // J. Biol. Chem. -2003. Vol. 24. — P. 2249−2255.
- Frizelle, S.P. Re-expression of pl6INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression. // Oncogene. 1998. -Vol. 16.-P. 3087−3095.
- Fukuoka, K. pl6INK4 expression is associated with increased sensitivity of human non-small cell lung cancer cells to DNA topoisomerase I inhibitors. // Jpn. J. Cancer Res. 1997.-Vol. 88.-P. 1009−1016.
- Furnari В., Blasina A., Boddy M.N. et al. Cdc25 inhibited in vivo and in vitro by checkpoint kinases Cdsl and Chkl. // Mol. Biol. Cell. 1999. — Vol.10. — P. 833−845.
- Gardai S.J., McPhillips K.A., Frasch S.C. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. // Cell. 2005. — Vol. 21. — P. 321−334.
- Gupta M., Fan S.J., Zhan Q.M. et al. Inactivation of p53 increases the cytotoxicity of camptothecin in human colon HCT116 and breast MCF-7 cancer cells. // Clin. Cancer Res. 1997. — Vol. 3. — P. 1653−1660.
- Harbour J.W., Luo, R.X., DeiSanti A. et al. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through Gl. // Cell. 1999. — Vol.98. — P. 859−869.
- Hershko Т., Ginsberg D. Up-regulation of Bcl-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis. // J. Biol. Chem. 2004. — Vol. 279(10). P. 86 278 634.
- Hill M.M., Adrain C., Martin S.J. Portrait of a killer: the mitochondrial apoptosome emerges from the shadows. // Mol. Interv. 2003. -Vol. 3(1) — P. 19−26.
- Hirota Т., Kunitoku N., Sasayama T. et al. Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells. // Cell. 2003. — Vol. 114. — P. 585−598.
- Hitoshi Y., Lorens J., Kitada S.I. Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells. // Immunity. 1998. — Vol. 8(4). — P. 461−71.
- Hockenbery D.M., Oltvai Z.N., Yin X.M. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. // Cell. 1993. — Vol. 75(2). — P. 241−251.
- Hoeppner D.J., Hengartner M.O., Schnabel R. Engulfment genes cooperate with ced-3 to promote cell death in Caenorhabditis elegans. // Nature. 2001. — Vol. 12. -P. 133−135.
- Hofmann K., Bucher P., Kajava A.V. et al. A model ofCdc25 phosphatase catalytic domain and Cdk-interaction surface based on the presence of a rhodanese homology domain. // J. Mol. Biol. 1998. — Vol. 282. — P. 195−208.
- Igney F.H., Krammer PH. Death and anti-death: tumour resistance to apoptosis. // Nat. Rev. Cancer. 2002. — Vol. 2(4). — P. 277−288.
- Igney FH, Krammer PH. Death and anti-death: tumour resistance to apoptosis. // Nat. Rev. Cancer. 2002. — Vol. 2. — P. 277−288.
- Innocente SA, Abrahamson JL, Cogswell JP et al., p53 regulates a G2 checkpoint through cyclin В17/ Proc. Natl. Acad. Sci. USA. 1999. — Vol. 96. — P. 2147−2152.
- Jacks, T. Tumor suppressor gene mutations in mice. // Ann. Rev. Genet. — 1996.-Vol. 30.-P. 603−636.
- Jacotot E., Costantini P., Decaudin D., et al. Mitochondrion as a novel target of anticancer chemotherapy. // J. Natl. Cancer Inst. 2000. — Vol. 13. — P.1042−1053.
- Jacotot E., Costantini P., Laboureau E. Mitochondrial membrane permeabilization during the apoptotic process. // Ann. N Y Acad. Sci. 1999. — Vol. 887. -P. 18−30.
- Jiang H., Chou H.S., Zhu, L. Requirement of cyclinE-cdk2 inhibition inp 16INK4a-mediated growth suppression. // Mol. Cell. Biol. 1998. — Vol. 18. — P. 52 845 290.
- Jimenez В., Volpert O.V., Crawford S.E. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. // Nat. Med. 2000. -Vol. 6-P. 41−48.
- Jin X., Nguyen D., Zhang W. Cell cycle arrest and inhibition of tumor cell proliferation the pl6INK4 gene mediated by an adenovirus vector. // Cancer Res. 1995. -Vol. 55.-P. 3250−3253.
- JozaN., Susin S.A., Daugas E. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. // Nature. 2001. — Vol. 29. — P. 549−554.
- Kang B.H., Ко E., Kwon O.K. The structure of procaspase 6 is similar to that of active mature caspase 6. // Biochem. J. 2002. — Vol. 15. — P. 629−634.
- Katayose, Y. Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27. // Cancer Res. 1997. — Vol. 57. — P. 5441−5445.
- Kaufmann S.H., Earnshaw W.C. Induction of apoptosis by cancer chemotherapy. // Exp. Cell. Res. 2000. — Vol. 256. — P. 42−49.
- Kischkel F.C., Hellbardt S., Behrmann I. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. // EMBO J. 1995. — Vol. 15. — P. 5579−5588.
- Kluck R.M., Bossy-Wetzel E., Green D.R. The release of cytochrome с from mitochondria: a primary site for Bcl-2 regulation of apoptosis. // Science. 1997. — Vol. 275(5303). P. — 1132−1136.
- Korsmeyer S.J., Wei M.C., Saito M. Pro-apoptotic cascade activates BID, which oligomerizes ВАК or BAX into pores that result in the release of cytochrome c. // Cell Death Differ. 2000. — Vol. 7(12). P. 1166−1173.
- Koumenis C., Giaccia A. Transformed cells require continuous activity of RNA polymerase II to resist oncogene-induced apoplosis. // Moll. Cell. Biol. -1997.- Vol. -17(12).-P. 7306−7316.
- Krajewski S., Krajewska M., Turner B.C. Prognostic significance of apoptosis regulators in breast cancer. // Endocr. Relat. Cancer. 1999. — Vol. 6(1). — P. 29−40.
- Lammer C., Wagerer S., Saffrich. et al. The cdc25B phosphatase is essential for the G2/M phase transition in human cells. // J. Cell Sci. 1998. — Voll. 11. -P. 24 452 453.
- Lang R.A., Bishop J.M. Macrophages are required for cell death and tissue remodeling in the developing mouse eye. // Cell. 1993. — Vol. 13. — P. 453−462.
- Liu F., Stanton J., Wu, Z. et al. The human Mytl kinase preferentially phosphorylates Cdc2 on threonine 14 and localizes to the endoplasmic reticulum and Golgi complex. // Mol. Cell Biol. 1997. — Vol. 17. — P. 571−583.
- Liu Q., Guntuku S., Cui S. et al. Chkl is an essential kinase that is regulated by Atr and required for the G (2)/M DNA damage checkpoint. // Genes Dev. 2000. -Vol. 14.-P. 1448−1459.
- Ljungman M. Lane DP Opinion: transcription guarding the genome by sensing DNA damage. // Nat. Rev. Cancer. — 2004. — Vol. 4(9). — P. 727−737.
- Ljungman M., Zhang Fl-', Chen H., e' al Inhibition of RXA polymerase 11 as a trigger for the p53 response. // Oncogene. 1999. — Vol. 18(3). — P. 583 — 592.
- Locksley R.M., Killeen N., Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. // Cell. 2001. — Vol. 23. — P. 487−501.
- Locksley R.M., Reiner S.L., Hatam F., et al. Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice. // Science. 1993. — Vol. 10. — P. 14 481 451.
- Majno G., Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. // Am. J. Pathol. 1995. — Vol. 146. — P. 3−15.
- Martinvalet D., Zhu P., Lieberman J. Granzyme A induces caspase-independent mitochondrial damage, a required first step for apoptosis. // Immunity. -2005. Vol. 22. — P. 355−370.
- Marumoto Т., Hirota Т., Morisaki T. et al. Roles of aurora-A kinase in mitotic entry and G2 checkpoint in mammalian cells. // Genes Cells. — 2002. Vol. 7. — P. 11 731 182.
- Melino G., Bernassola F., Ranalli M. p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation. // J. Biol. Chem. 2004. — Vol. 279(9).-P. 8076−8083.
- Mellon I., Spivak G., Hanawalt P.C. Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene. // Cell. 1997.-Vol. 51.-P. 241−249.
- Metzstein M.M., Stanfield G.M., Horvitz H.R. Genetics of programmed cell death in C. elegans: past, present and future. // Trends Genet. 1998. — Vol. 14(10). — P. 410−416.
- Mueller P.R., Coleman T.R., Dunphy W.G. Mytl: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine- 15. // Science. 1995. — Vol.270. — P. 86−90.
- Newmeyer D.D., Bossy-Wetzel E., Kluck R.M. Bcl-xL does not inhibit the function of Apaf-1. // Cell Death Differ. 2000. — Vol. 7(4). — P. 402−407.
- Nicotera P., Leist M., Ferrando-May E. Apoptosis and necrosis: different execution of the same death. // Biochem. Soc. Symp. 1999. — Vol. 66. — P. 69−73.
- Nigg, E.A. Mitotic kinases as regulators of cell division and its checkpoints. // Nat. Rev. Mol. Cell Biol. 2001. — Vol. 2. — P. 21−32.
- Nunez G., Benedict M.A., Hu Y. Caspases: the proteases of the apoptotic pathway. // Oncogene. 1998. — Vol. 24. — P. 3237−3245.
- O’Connell, M.J., Raleigh, J.M., Verkade, H.M. et al. Chk 1 is a weeJ kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation. // EMBO J. 1997. — Vol. 16. — P. 545−554.
- Ohki R., Murasawa H., Nemoto J. Noxa, a ВНЗ-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. // Science. 2000. — Vol. 12. -P. 1053−1058.
- Passalaris T.M., Benanti, J.A., Galloway D.A. et al. The G (2) checkpoint is maintained by redundant pathways. // Mol. Cell Biol. 1999. — Vol. 19. — P. 5872−5881.
- Puduvalli V.K., Saito Y., Xu R. Fenretinide activates caspases and induces apoptosis in gliomas. // Clin. Cancer Res. 1999. — Vol. 5(8). — P. 2230−2235.
- Puthalakath H., Huang D.C., O’Reilly L.A. The proapoptotie activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. // Mol. Cell. 1999. — Vol. 3(3). — P. 287−296.
- Rai N.K., Suryabhan, Ansari M. et al. Effect of glycaemic control on apoptosis in diabetic wounds. // J. Wound Care. 2005. — Vol.14. — P. 277−281.
- Rai N.K., Tripathi K. Apoptosis: a basic physiologic process in wound healing. // Int. J. Low Extrern. Wounds. 2005. — Vol. 4. — P. 138−144.
- Reddien P.W., Cameron S., Horvitz H.R. Phagocytosis promotes programmed cell death in C. elegans. // Nature. 2001. — Vol. 12. — P. 198−202.
- Reed J.C., Zha H., Aime-Sempe C, Takayama S, Structure-function analysis of Bcl-2 family proteins. Regulators of programmed cell death. // Adv. Exp. Med. Biol. — 1996.-Vol. 406. P. 99−112.
- RPA and ATR link transcriptional stress to p53. // Proc. Natl. Acad. Sci. USA -2007.-Vol. 104(31).-P. 12 778−12 783.
- Rubio-Moscardo F., Blesa D., Mestre C. Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes. // Blood. 2005. — Vol. 106. — P. 3214−3222.
- Ryan K.M., Ernst M.K., Rice N.R. Role of NF-kappaB in p53-mediated programmed cell death. // Nature. 2000. — Vol. 404. — P. 892−897.
- Sandig V. Adenovirally transferred pl6INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death. // Nat. Med. 1997. — Vol. 3. — P. 313— 319.
- Savill J., Fadok V. Corpse clearance defines the meaning of cell death. // Nature. 2000. — Vol. 12(6805). — P. 784−788.
- Scaffidi С, Kirchhoff S, Krammer PH. Apoptosis signaling in lymphocytes. // Curr. Opin. Immunol. 1999. — Vol. 11. — P. 277−285.
- Schimmer A.D. Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. // Cancer Res. 2004. — Vol. 15. — P. 7183−7190.
- Schmitt, E., Boutros, R., Froment, C. et al. CHK1 phosphorylates CDC25B during the cell cycle in the absence of DNA damage. // J. Cell Sci. 2006. — Vol.119. — P. 4269−4275.
- Schuler M., Green D.R. Mechanisms of p53-dependent apoptosis. // Biochem Soc Trans. 2001. — Vol. 29. — P. 684−688.
- Schuler M., Green D.R. Transcription, apoptosis and p53: catch-22. // Trends Genet.-2005.-Vol. 21.-P. 182−187.
- Sherr C.J., Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. // Genes Dev. 1999. — Vol. 13. — P. 1501−1512.
- Sherr, C.J., Roberts, J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. // Genes. 1995. — Vol. 9. — P. 1149−1163.
- Shiloh S., Illness representations, self-regulation, and genetic counseling: a theoretical review. // J. Genet. Couns. 2006. 15(5). P. 325−337.
- Shiloh Y. ATM and ATR: networking cellular responses to DNA damage. // Curr. Opin. Genet. Dev. 2001. — Vol. 11. — P. 71−77.
- Shimizu S., Eguchi Y., Kamiike W. Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux. // Proc. Natl. Acad. Sci. USA 1998. — Vol. 95(4).-P. 1455−1519.
- Shimizu S., Yamabe K., Kamiike W. et al. Prevention of hypoxic liver cell necrosis by in vivo human bcl-2 gene transfection. // Biochem. Biophys. Res. Commun. -1998.-Vol. 4.-P. 217−223.
- Slee E.A., Adrain C., Martin S.J. Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. // J. Biol. Chem. -2001. Vol. — 276. — P. 7320−7326.
- Smits V.A., Klompmaker R., Arnaud L. et al. Polo-like kinase-1 is a target of the DNA damage checkpoint. // Nat. Cell Biol. 2000. — Vol. 2. — P. 672−676.
- Stiewe Т., Putzer B.M. Role of the p53-homologue p73 in E2Fl-induced apoptosis. // Nat. Genet. 2000. — Vol. 26. — P. 464−469.
- Suliman I.A., Lindgren J.U., Elhassan A.M. Effects of short- and long-term rat hind limb immobilization on spinal cord insulin-like growth factor-I and its receptor. // Brain Res. 2001. — Vol. 31. — P. 17−23.
- Susin S.A., Zamzami N., Castedo M. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. // J. Exp. Med. 1996. — Vol. 184(4). — P. 1331−1341.
- Svejstrup JQ. Mechanisms of transcription-coupled DNA repair. // Nat. Revv Mol. Cell Bio. 2002. — Vol. 3(1). — P. 21−29.
- Tamatani M., Che Y.H., Matsuzaki H. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. // J. Biol. Chem. 1999. — Vol. 274(13).-P. 8531−8538.
- Tanaka N., Ishihara M., Lamphier M.S. et al. Cooperation of the tumour suppressors Irf-1 and p53 in response to DNA damage. // Nature. 1996. — Vol. 382. — P. 816−818.
- Transcriptional blockade induces p53-dependent apoptosis associated with translocation of p53 to mitochondria. // J. Biol. Chem. 2005. — Vol. 280(19). — P. 19 166−19 176.
- Vaux D.L., Silke J. IAPs, RINGs and ubiquitylation. // Nat. Rev. Mol. Cell Biol. 2005. — Vol. 6(4). — P. 287−297.
- Verhagen A.M., Ekert P.G., Pakusch M. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. // Cell. 2000. — Vol. 102(1). — P. 43−53.
- Wajant H., Pfizenmaier K., Scheurich P. TNF-related apoptosis inducing ligand (TRAIL) and its receptors in tumor surveillance and cancer therapy. // Apoptosis. -2002.-7(5).-P. 449−459.
- Wang C.Y., Guttridge D.C., Mayo M.W. et al. NF-kappaB induces expression of the Bcl-2 homologue Al/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. // Mol. Cell Biol. 1999. — Vol. 35. — P. 123−130.
- Xie S., Wu H., Wang Q. et al. Plk3 functionally links DNA damage to cell cycle arrest and apoptosis at least in part via the p53 pathway. // J. Biol. Chem. 2001. -Vol. 276.-P. 43 305−43 312.
- Yamaizumi M. Sugano T. IJV-mduced nuclear accumulation of p53 is evoked through DNA damage of actively transcribed genes independent of the cell cycle. // Oncogene. 1994. — Vol. 9(10). — P. 2775−2784.
- Zamzami N., Kroemer G. The mitochondrion in apoptosis: how Pandora’s box opens. //Nat. Rev. Mo. l Cell Biol. -2001. Vol. 2(1). — P. 67−71.
- Zamzami N., Marchetti P., Castedo M. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. // J. Exp. Med. 1995. Vol. 182(2). — P. 367−377.
- Zeiss C.J. The apoptosis-necrosis continuum: insights from genetically altered mice. // Vet. Pathol. 2003. — Vol. 40(5). — P. 481−495.
- Zhan, Q., Antinore, M.J., Wang, X.W. Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45. // Oncogene. -1999. Vol. 18.-P. 2892−2900.
- Zoratti M., Szabo I. The mitochondrial permeability transition. // Biochim. Biophys. Acta. 1995. — Vol. 1241(2). — P. 139−176.
- Zoratti M., De Marchi U., Gulbins E., et al. Novel channels of the inner mitochondrial membrane. // Biochim. Biophys. Acta. 2009. — Vol. 1787. — P. 351−363.
- Zoratti M., De Marchi U., Basso E., et al. Electrophysiological characterization of the Cyclophilin D-deleted mitochondrial permeability transition pore. // Mol. Membr. Biol. -2006.-Vol. 23.-P. 521−530.